DEFA14A: Jaguar Health Amends Proxy Statement Following NYSE Ruling on Adjournment Proposal

Jaguar Health issues a supplement to its definitive proxy statement, clarifying that Proposal 5 regarding adjournment of the annual meeting is now considered a non-routine matter by the NYSE, impacting broker voting rules.

Summary

• Jaguar Health has issued a supplement to its proxy statement dated May 21, 2024, for the upcoming Annual Meeting of Stockholders on June 21, 2024.
• The supplement addresses a notification from the New York Stock Exchange (NYSE) regarding Proposal 5, which concerns granting discretionary authority to adjourn the Annual Meeting to solicit additional proxies if needed to approve Proposal 4.
• Proposal 4 involves amending the company's 2014 Stock Incentive Plan to increase the number of shares of Common Stock authorized for issuance by 45,500,000 shares (equivalent to 758,333 shares after the 1-for-60 reverse stock split on May 23, 2024).
• The NYSE has ruled that Proposal 5 is a non-routine matter, meaning brokerage firms cannot vote uninstructed shares on this proposal.
• The supplement clarifies the rules regarding broker voting, distinguishing between routine and non-routine matters.
• Brokers have discretionary authority to vote on routine matters if they don't receive instructions from beneficial owners at least 10 days before the meeting, provided proxy materials were sent to the beneficial owner at least 15 days before the meeting.
• However, brokers do not have discretionary authority to vote on non-routine matters without timely instructions from the beneficial owner, resulting in a broker non-vote.
• Broker non-votes will be counted for quorum purposes but not treated as votes cast on non-routine matters.
• Proposal 2, ratifying the appointment of RBSM as the independent registered public accounting firm for the fiscal year ending December 31, 2024, is considered a routine matter.
• Proposals 1 (election of Class III director), 3 (advisory vote on executive compensation), 4 (amendment to the 2014 Stock Incentive Plan), and 5 (adjournment authority) are considered non-routine matters.

Sentiment

Score: 7

Explanation: The document is a neutral procedural update. It clarifies voting rules and doesn't contain overtly positive or negative information. The sentiment is therefore moderately neutral.

Future Outlook

The document does not contain specific forward-looking statements beyond the procedural aspects of the upcoming annual meeting.

Industry Context

This announcement is typical for publicly traded companies needing to ensure compliance with exchange rules regarding proxy voting and corporate governance.

Stakeholder Impact

• Shareholders need to be aware of the changes in broker voting rules, particularly for Proposal 5.
• Brokers need to understand the distinction between routine and non-routine matters for voting purposes.

Next Steps

• Stockholders should review the supplemented proxy statement.
• Stockholders should provide voting instructions to their brokers, especially for non-routine matters.

Key Dates

Keywords

proxy statement, Jaguar Health, NYSE, broker voting, annual meeting, stock incentive plan, reverse stock split, non-routine matter, adjournment proposal